-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Da94SdQomGsvi4zlOd24XVXKiD2saQT0MXjvHgsk6YIJWdfZufC+5g4FoL62Tnk9 g1bl3c/JVmWn6xA+F/z0FA== 0001341004-10-000510.txt : 20100316 0001341004-10-000510.hdr.sgml : 20100316 20100316134145 ACCESSION NUMBER: 0001341004-10-000510 CONFORMED SUBMISSION TYPE: SC 13D/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20100316 DATE AS OF CHANGE: 20100316 GROUP MEMBERS: APTAFIN S.P.A. GROUP MEMBERS: CHAUMIERE - CONSULTADORIA & SERVICOS SDC UNIPESSOAL LDA FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: CAVAZZA PAOLO CENTRAL INDEX KEY: 0001163608 FILING VALUES: FORM TYPE: SC 13D/A MAIL ADDRESS: STREET 1: VIA TESSERETE, 10 CITY: LUGANO STATE: V8 ZIP: V8 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: QUESTCOR PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000891288 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 330476164 STATE OF INCORPORATION: CA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13D/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-43062 FILM NUMBER: 10684821 BUSINESS ADDRESS: STREET 1: 3260 WHIPPLE ROAD CITY: UNION CITY STATE: CA ZIP: 94587-1217 BUSINESS PHONE: 5104000700 MAIL ADDRESS: STREET 1: 3260 WHIPPLE ROAD CITY: UNION CITY STATE: CA ZIP: 94587-1217 FORMER COMPANY: FORMER CONFORMED NAME: CYPROS PHARMACEUTICAL CORP DATE OF NAME CHANGE: 19930328 SC 13D/A 1 sc13da16.htm SCHEDULE 13D, AMENDMENT NO. 16 sc13da16.htm
 
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549

SCHEDULE 13D
[Rule 13d-101]

INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT
TO §240.13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO
§240.13d-2(a)
(Amendment No. 16)*


QUESTCOR PHARMACEUTICALS, INC.
(Name of Issuer)
 
Common Stock
(Title of Class of Securities)
 
74835Y101
(CUSIP Number)
 
 
Gregg A. Noel, Esq.
 
Skadden, Arps, Slate, Meagher & Flom LLP
 
300 South Grand Avenue, Suite 3400
 
Los Angeles, CA 90071
(213) 687-5000
(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)
 
March 15, 2010
(Date of Event Which Requires Filing of this Statement)
 
If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§240.13d-1(e), 240.13d-1(f) or 240.13d-(1)(g), check the following box ¨.
 
*The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.
 
The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).
 
 
 

 

CUSIP No. 74835Y101
13D
Page 2 of 13 Pages

 
1
NAMES OF REPORTING PERSONS
 
Paolo Cavazza
 
2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
 
 
(a) T
(b) o
3
SEC USE ONLY
 
 
 
4
SOURCE OF FUNDS
 
 
 
5
CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED
PURSUANT TO ITEM 2(d) OR 2(e)
 
 
 
c
6
CITIZENSHIP OR PLACE OF ORGANIZATION
 
Italy
 
 
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON WITH
7
SOLE VOTING POWER
0
 
8
SHARED VOTING POWER
3,930,000
 
 
9
SOLE DISPOSITIVE POWER
0
 
10
SHARED DISPOSITIVE POWER
3,930,000
 
11
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
 
3,930,000
12
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES
 
 
¨
13
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
 
6.34%
14
TYPE OF REPORTING PERSON
 
IN

 
 

 

CUSIP No. 74835Y101
13D
Page 3 of 13 Pages

 
1
NAMES OF REPORTING PERSONS
 
Aptafin S.p.A.
 
2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
 
 
(a) T
(b) o
3
SEC USE ONLY
 
 
 
4
SOURCE OF FUNDS
 
 
 
5
CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED
PURSUANT TO ITEM 2(d) OR 2(e)
 
 
 
c
6
CITIZENSHIP OR PLACE OF ORGANIZATION
 
Italy
 
 
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON WITH
7
SOLE VOTING POWER
0
 
8
SHARED VOTING POWER
3,930,000
 
 
9
SOLE DISPOSITIVE POWER
0
 
10
SHARED DISPOSITIVE POWER
3,930,000
 
11
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
 
3,930,000
12
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES
 
 
¨
13
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
 
6.34%
14
TYPE OF REPORTING PERSON
 
CO

 
 

 

CUSIP No. 74835Y101
13D
Page 4 of 13 Pages

 
1
NAMES OF REPORTING PERSONS
 
Chaumiere - Consultadoria & Servicos SDC Unipessoal LDA
 
2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
 
 
(a) T
(b) o
3
SEC USE ONLY
 
 
 
4
SOURCE OF FUNDS
 
 
 
5
CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED
PURSUANT TO ITEM 2(d) OR 2(e)
 
 
 
c
6
CITIZENSHIP OR PLACE OF ORGANIZATION
 
Italy
 
 
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON WITH
7
SOLE VOTING POWER
0
 
8
SHARED VOTING POWER
3,930,000
 
 
9
SOLE DISPOSITIVE POWER
0
 
10
SHARED DISPOSITIVE POWER
3,930,000
 
11
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
 
3,930,000
12
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES
 
 
¨
13
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
 
6.34%
14
TYPE OF REPORTING PERSON
 
CO

 
 

 

CUSIP No. 74835Y101
13D
Page 5 of 13 Pages


Amendment No. 16 to
Statement on Schedule 13D

This Amendment No. 16 (this “Amendment No. 16”) amends the Statement on Schedule 13D, filed with the Securities and Exchange Commission (the “SEC”) on August 7, 2001, as amended (the “Schedule 13D”), relating to the shares of common stock, no par value (the “Common Stock”), of Questcor Pharmaceuticals, Inc., a California Corporation (“Questcor”).  Pursuant to Rule 13d-2 of Regulation 13D-G promulgated under the Securities Exchange Act of 1934, as amended (the “Act”), this Amendment No. 16 is being filed on behalf of Mr. Paolo Cavazza (“Mr. P. Cavazza”), Aptafin S.p.A., an Italian corporation (“Aptafin”) and Chaumiere - Consultadoria & Servicos SDC Unipessoal LDA, a Portuguese corporation (“Chaumiere” and, together with Mr. P. Cavazza and Aptafin, the “Reporting Persons”).  Previously, the Reporting Persons affirmed membership in a “group” for purposes of Section 13(d) and 13(g) of the Act with Sigma Tau Finanziaria SpA, an Italian corporation (“Sigma Tau”), Defiante Farmaceutica L.D.A., a Portuguese corporation (“Defiante”) (formerly known as Defiante Farmaceutica Unipessoal L.D.A.), Sigma-Tau International S.A., a Luxembourg corporation (“Sigma Tau International”) (formerly known as Sigma-Tau Finance Holding S.A.), Inverlochy Consultadoria & Servicos L.D.A., a Portuguese corporation (“Inverlochy”) and Mr. Claudio Cavazza (“Mr. C. Cavazza” and, together with Sigma Tau, Defiante, Sigma Tau International and Inverlochy, the “Former Group Members”).  Pursuant to Amendment No. 13 to the Schedule 13D, the Reporting Persons indicated that they are no long er members of a “group” with the Former Group Members.  As such, this Amendment No. 16 is filed solely with respect to the Reporting Persons’ beneficial ownership of Common Stock.

Item 5.                      Interest in Securities of the Issuer.
 
Item 5 subsections (a) – (c) of the Schedule 13D are hereby amended as follows:
 
(a)           Percentage interest calculations for the Reporting Persons are based upon Questcor having 62,018,979 million shares of Common Stock outstanding as of March 3, 2010 (the “Outstanding Shares”), as reported by Questcor in Questcor’s Annual Report on Form 10-K filed with the SEC on March 16, 2010.

Mr. P. Cavazza
 
Pursuant to Rule 13d-3 of the Act, Mr. P. Cavazza may be deemed to be the beneficial owner of 3,930,000 shares of Common Stock, which constitutes approximately 6.34% of the Outstanding Shares.
 
Aptafin
 
Pursuant to Rule 13d-3 of the Act, Aptafin may be deemed to be the beneficial owner of 3,930,000 shares of Common Stock, which constitutes approximately 6.34% of the Outstanding Shares.
 
Chaumiere
 
Pursuant to Rule 13d-3 of the Act, Chaumiere may be deemed to be the beneficial owner of 3,930,000 shares of Common Stock, which constitutes approximately 6.34% of the Outstanding Shares.
 
(b)           Mr. P. Cavazza
 
The number of shares of Common Stock as to which Mr. P. Cavazza has the sole power to vote or direct the vote is zero.  The number of shares of Common Stock as to which Mr. P. Cavazza shares the power to vote or direct the vote is 3,930,000.  The number of shares of Common Stock as to which Mr. P. Cavazza has the sole power to dispose or direct the disposition is zero.  The number of shares of Common Stock as to which Mr. P. Cavazza shares the power to dispose or direct the disposition is 3,930,000.
 
Aptafin

 
 

 

CUSIP No. 74835Y101
13D
Page 6 of 13 Pages

 
The number of shares of Common Stock as to which Aptafin has the sole power to vote or direct the vote is zero.  The number of shares of Common Stock as to which Aptafin shares the power to vote or direct the vote is 3,930,000.  The number of shares of Common Stock as to which Aptafin has the sole power to dispose or direct the disposition is zero.  The number of shares of Common Stock as to which Aptafin shares the power to dispose or direct the disposition is 3,930,000.

Chaumiere
 
The number of shares of Common Stock as to which Chaumiere has the sole power to vote or direct the vote is zero.  The number of shares of Common Stock as to which Chaumiere shares the power to vote or direct the vote is 3,930,000.  The number of shares of Common Stock as to which Chaumiere has the sole power to dispose or direct the disposition is zero.  The number of shares of Common Stock as to which Chaumiere shares the power to dispose or direct the disposition is 3,930,000.

(c)           The following table sets forth the transactions in the Common Stock effected by the Reporting Persons during the past 60 days:
 
Date
Party
Type of Transaction
Type of Security
Number of Shares
Price Per Share
           
03/15/2010
Chaumiere
Open market sale
Common Stock
200
$6.8200
           
03/15/2010
Chaumiere
Open market sale
Common Stock
500
$6.8150
           
03/15/2010
Chaumiere
Open market sale
Common Stock
1,300
$6.8100
           
03/15/2010
Chaumiere
Open market sale
Common Stock
1,000
$6.8050
           
03/15/2010
Chaumiere
Open market sale
Common Stock
2,300
$6.8000
           
03/15/2010
Chaumiere
Open market sale
Common Stock
2,100
$6.7900
           
03/15/2010
Chaumiere
Open market sale
Common Stock
2,000
$6.7850
           
03/15/2010
Chaumiere
Open market sale
Common Stock
4,600
$6.7800
           
03/15/2010
Chaumiere
Open market sale
Common Stock
2,400
$6.7750
           
03/15/2010
Chaumiere
Open market sale
Common Stock
200
$6.7730
           
03/15/2010
Chaumiere
Open market sale
Common Stock
11,154
$6.7700
           
03/15/2010
Chaumiere
Open market sale
Common Stock
7,500
$6.7650
           
03/15/2010
Chaumiere
Open market sale
Common Stock
18,496
$6.7600

 
 

 

CUSIP No. 74835Y101
13D
Page 7 of 13 Pages

 
03/15/2010
Chaumiere
Open market sale
Common Stock
400
$6.7580
           
03/15/2010
Chaumiere
Open market sale
Common Stock
5,100
$6.7550
           
03/15/2010
Chaumiere
Open market sale
Common Stock
10,750
$6.7500
           
03/11/2010
Chaumiere
Open market sale
Common Stock
1,200
$6.9650
           
03/11/2010
Chaumiere
Open market sale
Common Stock
4,400
$6.9600
           
03/11/2010
Chaumiere
Open market sale
Common Stock
1,700
$6.9550
           
03/11/2010
Chaumiere
Open market sale
Common Stock
400
$6.9400
           
03/11/2010
Chaumiere
Open market sale
Common Stock
1,600
$6.9350
           
03/11/2010
Chaumiere
Open market sale
Common Stock
400
$6.9300
           
03/11/2010
Chaumiere
Open market sale
Common Stock
400
$6.9250
           
03/11/2010
Chaumiere
Open market sale
Common Stock
100
$6.9150
           
03/11/2010
Chaumiere
Open market sale
Common Stock
100
$6.9100
           
03/11/2010
Chaumiere
Open market sale
Common Stock
300
$6.9050
           
03/11/2010
Chaumiere
Open market sale
Common Stock
100
$6.9000
           
03/11/2010
Chaumiere
Open market sale
Common Stock
300
$6.8950
           
03/11/2010
Chaumiere
Open market sale
Common Stock
800
$6.8900
           
03/11/2010
Chaumiere
Open market sale
Common Stock
400
$6.8850
           
03/11/2010
Chaumiere
Open market sale
Common Stock
900
$6.8800

 
 

 

CUSIP No. 74835Y101
13D
Page 8 of 13 Pages

 
03/11/2010
Chaumiere
Open market sale
Common Stock
100
$6.8750
           
03/11/2010
Chaumiere
Open market sale
Common Stock
900
$6.8700
           
03/11/2010
Chaumiere
Open market sale
Common Stock
500
$6.8650
           
03/11/2010
Chaumiere
Open market sale
Common Stock
3,070
$6.8600
           
03/11/2010
Chaumiere
Open market sale
Common Stock
100
$6.8550
           
03/11/2010
Chaumiere
Open market sale
Common Stock
200
$6.8510
           
03/11/2010
Chaumiere
Open market sale
Common Stock
1,330
$6.8500
           
03/11/2010
Chaumiere
Open market sale
Common Stock
1,500
$6.8450
           
03/11/2010
Chaumiere
Open market sale
Common Stock
100
$6.8425
           
03/11/2010
Chaumiere
Open market sale
Common Stock
1,200
$6.8400
           
03/11/2010
Chaumiere
Open market sale
Common Stock
400
$6.8350
           
03/11/2010
Chaumiere
Open market sale
Common Stock
1,944
$6.8300
           
03/11/2010
Chaumiere
Open market sale
Common Stock
500
$6.8250
           
03/11/2010
Chaumiere
Open market sale
Common Stock
2,200
$6.8200
           
03/11/2010
Chaumiere
Open market sale
Common Stock
1,100
$6.8100
           
03/11/2010
Chaumiere
Open market sale
Common Stock
10,000
$6.8000
           
03/11/2010
Chaumiere
Open market sale
Common Stock
6,300
$6.7950
           
03/11/2010
Chaumiere
Open market sale
Common Stock
4,801
$6.7900
           
03/11/2010
Chaumiere
Open market sale
Common Stock
1,500
$6.7850

 
 

 

CUSIP No. 74835Y101
13D
Page 9 of 13 Pages

 
03/11/2010
Chaumiere
Open market sale
Common Stock
6,000
$6.7800
           
03/11/2010
Chaumiere
Open market sale
Common Stock
4,000
$6.7750
           
03/11/2010
Chaumiere
Open market sale
Common Stock
5,600
$6.7700
           
03/08/2010
Chaumiere
Open market sale
Common Stock
30,000
$6.7500
           
03/08/2010
Chaumiere
Open market sale
Common Stock
27,226
$6.5000
           
03/05/2010
Chaumiere
Open market sale
Common Stock
22,774
$6.5000
           
03/03/2010
Chaumiere
Open market sale
Common Stock
25,000
$6.0000
           
03/03/2010
Chaumiere
Open market sale
Common Stock
25,000
$5.7500
           
03/02/2010
Chaumiere
Open market sale
Common Stock
1,500
$5.6500
           
03/02/2010
Chaumiere
Open market sale
Common Stock
100
$5.6425
           
03/02/2010
Chaumiere
Open market sale
Common Stock
8,200
$5.6400
           
03/02/2010
Chaumiere
Open market sale
Common Stock
4,400
$5.6300
           
03/02/2010
Chaumiere
Open market sale
Common Stock
3,300
$5.6200
           
03/02/2010
Chaumiere
Open market sale
Common Stock
1,500
$5.6100
           
03/02/2010
Chaumiere
Open market sale
Common Stock
4,500
$5.6000
           
03/02/2010
Chaumiere
Open market sale
Common Stock
1,500
$5.5900
           
03/02/2010
Chaumiere
Open market sale
Common Stock
25,000
$5.5000
           
03/02/2010
Chaumiere
Open market sale
Common Stock
25,000
$5.2500
           
02/25/2010
Chaumiere
Open market sale
Common Stock
25,000
$4.7500

 
 

 

CUSIP No. 74835Y101
13D
Page 10 of 13 Pages

 
02/01/2010
Chaumiere
Open market sale
Common Stock
25,000
$4.5000
           
01/15/2010
Chaumiere
Open market sale
Common Stock
100
$5.0150
           
01/15/2010
Chaumiere
Open market sale
Common Stock
3,940
$5.0100
           
01/15/2010
Chaumiere
Open market sale
Common Stock
20,960
$5.0000
           
01/14/2010
Chaumiere
Open market sale
Common Stock
21,500
$5.0000
           
01/14/2010
Chaumiere
Open market sale
Common Stock
3,500
$5.0100
 
 
Item 7.    Material to be Filed as Exhibits.
 
Item 7 of the Schedule 13D is hereby amended to add the following:
 
EXHIBIT 28 – Joint Filing Agreement dated December 21, 2006 by and between the Reporting Persons and the Former Group Members (incorporated by reference to Exhibit 7 to the Schedule 13D).
 
EXHIBIT 29 – Power of Attorney dated February 29, 2008 by Paolo Cavazza (incorporated by reference to Exhibit 1 of Form 4, filed with the SEC on June 9, 2008, relating to the shares of Common Stock).
 
EXHIBIT 30 – Power of Attorney dated February 29, 2008 by Chaumiere – Consultadoria & Servicos SDC Unipessoal LDA (incorporated by reference to Exhibit 2 of Form 4, filed with the SEC on June 9, 2008, relating to the shares of Common Stock).
 
EXHIBIT 31 – Power of Attorney dated July 14, 2008 by Aptafin S.p.A. (incorporated by reference to Exhibit 1 of Form 4, filed with the SEC on July 18, 2008, relating to the shares of Common Stock).
 

 

 
 

 

CUSIP No. 74835Y101
13D
Page 11 of 13 Pages


Signatures
 
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement with respect to Paolo Cavazza is true, complete and correct.
 
Dated:  March 16, 2010
 
 
PAOLO CAVAZZA
   
   
 
By:
/s/ Fabio Poma
   
Fabio Poma, Attorney-in-fact for Paolo Cavazza
     
     
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement with respect to Aptafin S.p.A. is true, complete and correct.
 
Dated:  March 16, 2010
 
 
APTAFIN S.P.A.
   
   
 
By:
/s/ Fabio Poma
   
Fabio Poma, Attorney-in-fact for Aptafin S.p.A.
     
     
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement with respect to Chaumiere - Consultadoria & Servicos SDC Unipessoal LDA is true, complete and correct.
 
Dated:  March 16, 2010
 
 
CHAUMIERE - CONSULTADORIA & SERVICOS SDC UNIPESSOAL LDA
   
   
 
By:
/s/ Fabio Poma
   
Fabio Poma, Attorney-in-fact for Chaumiere - Consultadoria & Servicos SDC Unipessoal LDA
     
     
The original statement shall be signed by each person on whose behalf the statement is filed or his authorized representative.  If the statement is signed on behalf of a person by his authorized representative (other than an executive officer or general partner of the filing person), evidence of the representative’s authority to sign on behalf of such person shall be filed with the statement, provided, however, that a power of attorney for this purpose which is already on file with the Commission may be incorporated by reference.  The name of any title of each person who signs the statement shall be typed or printed beneath his signature.
 
 
Attention:  Intentional misstatements or omissions of fact constitute Federal criminal violations (see 18 U.S.C. 1001).

 
 

 

CUSIP No. 74835Y101
13D
Page 12 of 13 Pages


Schedule A
 
EXECUTIVE OFFICERS AND DIRECTORS
 
Aptafin S.p.A.
 
NAME
 
ADDRESS
 
TITLE
 
CITIZENSHIP
 
Cristina Cavazza
 
Viale Shakespeare, 47
00144 Rome Italy
 
President
 
Italian
 
Maurizio Terenzi
 
via Sudafrica,20,
00144 Rome Italy-
 
Managing Director
 
Italian
 
Antonio Nicolai
 
via Sudafrica,20,
00144 Rome Italy-
 
Director
 
Italian
 
Emanuela Cavazza
 
Viale Shakespeare 47
00144 Rome Italy-
 
Director
 
Italian
 
 


 
 

 

CUSIP No. 74835Y101
13D
Page 13 of 13 Pages


Schedule A
 
EXECUTIVE OFFICERS AND DIRECTORS
 
Chaumiere - Consultadoria & Servicos SDC Unipessoal LDA
 
NAME
 
ADDRESS
 
TITLE
 
CITIZENSHIP
 
Roberto Carlos de
Castro Abreu
 
Avenida da República, 32, 4.º Esquerdo, 1050-193 Lisboa, Portugal
 
Director
 
Portuguese
 
João Josè de Freitas
Rodrigues
 
Avenida da República, 32, 4.º Esquerdo, 1050-193 Lisboa, Portugal
 
Director
 
Portuguese
 

 
-----END PRIVACY-ENHANCED MESSAGE-----